📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
5 articles
AVG GRADE
NEUTRAL
score: 0.40
SENTIMENT
NEUTRAL
TOTAL VIEWS
8
RECENT COVERAGE · 6 ARTICLES
Viridian Therapeutics: Lumvoa Ready For Prime Time Following FDA Approval (NASDAQ:VRDN)
VRDN has secured FDA approval for Lumvoa, a therapeutic treatment in the thyroid eye disease (TED) space. This regulatory milestone...
Nearly 1 million bottles of heart and kidney medication recalled over foreign substance found on tablets
Amgen initiated a recall of approximately one million bottles of Corlanor (ivabradine) and Sensipar (cinacalcet) following FDA...
Amgen Continues To Perform (NASDAQ:AMGN)
Amgen (AMGN) continues to demonstrate operational resilience with analyst ratings clustering around Hold-to-Buy territory, suggesting...
Obesity drugs approach a major milestone, and Lilly may have a 'game changer' ahead
The obesity drug sector is approaching a critical inflection point, with Eli Lilly positioning itself as a potential market leader...
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
Amgen (AMGN) is experiencing increased user engagement on Zacks.com, signaling renewed retail and analyst interest in the...
7 Best Longevity Stocks to Buy Now
The longevity investment theme reflects structural demographic shifts toward aging populations and increased healthcare spending....
RELATED TICKERS
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice